Figure 4

Expression pattern of predicted transcription factors in different stages of prostate abnormality. Expression profiles of JUN, JUNB, JUND, EGR are from the same study in Oncomine database, which classifies prostate abnormality into four stages, normal prostate, benign prostatic hyperplasia, primary prostate cancer, and metastatic prostate cancer. FOS, FOSL1, FOSL2, STAT3 are from other two studies both of which include three subtypes, including normal prostate, and primary and metastatic prostate cancer. JUN, JUNB, JUND, FOS, FOSL1, FOSL2 bind to AP-1 binding site, EGR1 binds to KROX binding site, STAT3 binds to STAT3 binding site.